Clinical trial underway for batimastat-coated stent
This article was originally published in Clinica
Executive Summary
European researchers have begun a clinical trial to assess Biocompatibles International's BiodivYsio stent coated with British Biotech's drug batimastat as a tool for reducing restenosis in patients who have undergone coronary angioplasty.